Lin Celia 4
4 · Vera Therapeutics, Inc. · Filed May 17, 2021
Insider Transaction Report
Form 4
Lin Celia
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-05-13+16,916→ 16,916 totalExercise: $11.00Exp: 2031-05-12→ Class A Common Stock (16,916 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option vest on May 13, 2022, and 1/48 of the shares vest monthly thereafter.